A detailed history of Park Avenue Securities LLC transactions in Enovis Corp stock. As of the latest transaction made, Park Avenue Securities LLC holds 10,655 shares of ENOV stock, worth $468,287. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,655
Previous 9,162 16.3%
Holding current value
$468,287
Previous $414,000 10.87%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$40.57 - $48.1 $60,571 - $71,813
1,493 Added 16.3%
10,655 $459,000
Q2 2024

Jul 09, 2024

BUY
$44.56 - $62.43 $136,041 - $190,598
3,053 Added 49.98%
9,162 $414,000
Q1 2024

Apr 10, 2024

BUY
$55.44 - $63.8 $9,092 - $10,463
164 Added 2.76%
6,109 $382,000
Q4 2023

Jan 10, 2024

BUY
$43.67 - $57.07 $90,265 - $117,963
2,067 Added 53.3%
5,945 $333,000
Q3 2023

Oct 26, 2023

BUY
$51.65 - $65.54 $200,298 - $254,164
3,878 New
3,878 $204,000

Others Institutions Holding ENOV

About Enovis CORP


  • Ticker ENOV
  • Exchange NYSE
  • Sector Industrials
  • Industry Specialty Industrial Machinery
  • Shares Outstandng 54,129,500
  • Market Cap $2.38B
  • Description
  • Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...
More about ENOV
Track This Portfolio

Track Park Avenue Securities LLC Portfolio

Follow Park Avenue Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Avenue Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Park Avenue Securities LLC with notifications on news.